{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:31:11Z","timestamp":1790699471364,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL148852"],"award-info":[{"award-number":["R01HL148852"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL139487"],"award-info":[{"award-number":["R01HL139487"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL150832"],"award-info":[{"award-number":["R01HL150832"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL069438"],"award-info":[{"award-number":["R01HL069438"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK098263"],"award-info":[{"award-number":["R01DK098263"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK115577"],"award-info":[{"award-number":["R01DK115577"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"HHS | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA013330"],"award-info":[{"award-number":["P30CA013330"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004856","name":"New York State Department of Health","doi-asserted-by":"publisher","award":["C029154"],"award-info":[{"award-number":["C029154"]}],"id":[{"id":"10.13039\/100004856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004856","name":"New York State Department of Health","doi-asserted-by":"publisher","award":["C34874GG"],"award-info":[{"award-number":["C34874GG"]}],"id":[{"id":"10.13039\/100004856","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leukemia & Lymphoma Society","award":["1360\u201019"],"award-info":[{"award-number":["1360\u201019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2022,5,4]]},"DOI":"10.15252\/embr.202154262","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T05:20:13Z","timestamp":1646112013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0527-4505","authenticated-orcid":false,"given":"Claudia","family":"Morganti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Yanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Teruya\u2010Feldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6702-9735","authenticated-orcid":false,"given":"Keisuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"BFEMBR202154262_CR1","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/jcp.22561","volume":"226","author":"T Asai","year":"2011","unstructured":"Asai T, Liu Y, Bae N, Nimer SD (2011) The p53 tumor suppressor protein regulates hematopoietic stem cell fate. J Cell Physiol 226: 2215\u20132221","journal-title":"J Cell Physiol"},{"key":"BFEMBR202154262_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.leu.2404063","volume":"20","author":"R Berger","year":"2006","unstructured":"Berger R, Busson M, Baranger L, Helias C, Lessard M, Dastugue N, Speleman F (2006) Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements. Leukemia 20: 319\u2013321","journal-title":"Leukemia"},{"key":"BFEMBR202154262_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exphem.2018.10.012","volume":"68","author":"M Bonora","year":"2018","unstructured":"Bonora M, Ito K, Morganti C, Pinton P, Ito K (2018) Membrane\u2010potential compensation reveals mitochondrial volume expansion during HSC commitment. Exp Hematol 68:30\u201337","journal-title":"Exp Hematol"},{"key":"BFEMBR202154262_CR4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.celrep.2013.01.005","volume":"3","author":"K Brown","year":"2013","unstructured":"Brown K, Xie S, Qiu X, Mohrin M, Shin J, Liu Y, Zhang D, Scadden DT, Chen D (2013) SIRT3 reverses aging\u2010associated degeneration. Cell Rep 3: 319\u2013327","journal-title":"Cell Rep"},{"key":"BFEMBR202154262_CR5","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201541","volume":"218","author":"F Caiado","year":"2021","unstructured":"Caiado F, Pietras EM, Manz MG (2021) Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp Med 218:e20201541","journal-title":"J Exp Med"},{"key":"BFEMBR202154262_CR6","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1371\/journal.pbio.0050201","volume":"5","author":"SM Chambers","year":"2007","unstructured":"Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5: e201","journal-title":"PLoS Biol"},{"key":"BFEMBR202154262_CR7","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature07619","volume":"457","author":"MJ Chen","year":"2009","unstructured":"Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA (2009) Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 457: 887\u2013891","journal-title":"Nature"},{"key":"BFEMBR202154262_CR8","doi-asserted-by":"crossref","first-page":"44821","DOI":"10.18632\/oncotarget.8599","volume":"7","author":"A Di Matteo","year":"2016","unstructured":"Di Matteo A, Franceschini M, Chiarella S, Rocchio S, Travaglini\u2010Allocatelli C, Federici L (2016) Molecules that target nucleophosmin for cancer treatment: an update. Oncotarget 7: 44821\u201344840","journal-title":"Oncotarget"},{"key":"BFEMBR202154262_CR9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","volume":"352","author":"B Falini","year":"2005","unstructured":"Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, La Starza R, Diverio D, Colombo E, Santucci A et\u00a0al (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352: 254\u2013266","journal-title":"N Engl J Med"},{"key":"BFEMBR202154262_CR10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.stem.2012.04.007","volume":"10","author":"M Florian","year":"2012","unstructured":"Florian M, D\u00f6rr K, Niebel A, Daria D, Schrezenmeier H, Rojewski M, Filippi M\u2010D, Hasenberg A, Gunzer M, Scharffetter\u2010Kochanek K et\u00a0al (2012) Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell 10: 520\u2013530","journal-title":"Cell Stem Cell"},{"key":"BFEMBR202154262_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.beha.2013.09.004","volume":"26","author":"A Giagounidis","year":"2013","unstructured":"Giagounidis A, Haase D (2013) Morphology, cytogenetics and classification of MDS. Best Pract Res Clin Haematol 26: 337\u2013353","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFEMBR202154262_CR12","first-page":"4","volume":"19","author":"JE Goasguen","year":"1992","unstructured":"Goasguen JE, Bennett JM (1992) Classification and morphologic features of the myelodysplastic syndromes. Semin Oncol 19: 4\u201313","journal-title":"Semin Oncol"},{"key":"BFEMBR202154262_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature03915","volume":"437","author":"S Grisendi","year":"2005","unstructured":"Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP (2005) Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437: 147\u2013153","journal-title":"Nature"},{"key":"BFEMBR202154262_CR14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrc1885","volume":"6","author":"S Grisendi","year":"2006","unstructured":"Grisendi S, Mecucci C, Falini B, Pandolfi PP (2006) Nucleophosmin and cancer. Nat Rev Cancer 6: 493\u2013505","journal-title":"Nat Rev Cancer"},{"key":"BFEMBR202154262_CR15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/leu.2017.30","volume":"31","author":"EM Heath","year":"2017","unstructured":"Heath EM, Chan SM, Minden MD, Murphy T, Shlush LI, Schimmer AD (2017) Biological and clinical consequences of NPM1 mutations in AML. Leukemia 31: 798\u2013807","journal-title":"Leukemia"},{"key":"BFEMBR202154262_CR16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/leu.2009.82","volume":"23","author":"S Heinrichs","year":"2009","unstructured":"Heinrichs S, Kulkarni RV, Bueso\u2010Ramos CE, Levine RL, Loh ML, Li C, Neuberg D, Kornblau SM, Issa J\u2010P, Gilliland DG et\u00a0al (2009) Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics. Leukemia 23: 1605\u20131613","journal-title":"Leukemia"},{"key":"BFEMBR202154262_CR17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu Y, Smyth GK (2009) ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347: 70\u201378","journal-title":"J Immunol Methods"},{"key":"BFEMBR202154262_CR18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm1388","volume":"12","author":"K Ito","year":"2006","unstructured":"Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y et\u00a0al (2006) Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12: 446\u2013451","journal-title":"Nat Med"},{"key":"BFEMBR202154262_CR19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aaf5530","volume":"354","author":"K Ito","year":"2016","unstructured":"Ito K, Turcotte R, Cui J, Zimmerman SE, Pinho S, Mizoguchi T, Arai F, Runnels JM, Alt C, Teruya\u2010Feldstein J et\u00a0al (2016) Self\u2010renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance. Science 354: 1156\u20131160","journal-title":"Science"},{"key":"BFEMBR202154262_CR20","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1038\/s41375-018-0189-7","volume":"32","author":"JI Kida","year":"2018","unstructured":"Kida JI, Tsujioka T, Suemori SI, Okamoto S, Sakakibara K, Takahata T, Yamauchi T, Kitanaka A, Tohyama Y, Tohyama K (2018) An MDS\u2010derived cell line and a series of its sublines serve as an in\u00a0vitro model for the leukemic evolution of MDS. Leukemia 32: 1846\u20131850","journal-title":"Leukemia"},{"key":"BFEMBR202154262_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hoc.2010.02.004","volume":"24","author":"RS Komrokji","year":"2010","unstructured":"Komrokji RS, Zhang L, Bennett JM (2010) Myelodysplastic syndromes classification and risk stratification. Hematol Oncol Clin North Am 24: 443\u2013457","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFEMBR202154262_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012855","volume":"5","author":"R La Starza","year":"2010","unstructured":"La Starza R, Matteucci C, Gorello P, Brandimarte L, Pierini V, Crescenzi B, Nofrini V, Rosati R, Gottardi E, Saglio G et\u00a0al (2010) NPM1 deletion is associated with gross chromosomal rearrangements in leukemia. PLoS One 5: e12855","journal-title":"PLoS One"},{"key":"BFEMBR202154262_CR23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMoa1611604","volume":"376","author":"RC Lindsley","year":"2017","unstructured":"Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu Z\u2010H, Spellman SR, Lee SJ et\u00a0al (2017) Prognostic Mutations in Myelodysplastic Syndrome after Stem\u2010Cell Transplantation. N Engl J Med 376: 536\u2013547","journal-title":"N Engl J Med"},{"key":"BFEMBR202154262_CR24","doi-asserted-by":"crossref","first-page":"140532","DOI":"10.1016\/j.bbapap.2020.140532","volume":"1868","author":"DJ Lopez","year":"2020","unstructured":"Lopez DJ, Rodriguez JA, Banuelos S (2020) Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair. Biochim Biophys Acta Proteins Proteom 1868:140532","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"BFEMBR202154262_CR25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V82.4.1092.1092","volume":"82","author":"J Lotem","year":"1993","unstructured":"Lotem J, Sachs L (1993) Hematopoietic cells from mice deficient in wild\u2010type p53 are more resistant to induction of apoptosis by some agents. Blood 82: 1092\u20131096","journal-title":"Blood"},{"key":"BFEMBR202154262_CR26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.celrep.2018.12.101","volume":"26","author":"H Luo","year":"2019","unstructured":"Luo H, Mu WC, Karki R, Chiang HH, Mohrin M, Shin JJ, Ohkubo R, Ito K, Kanneganti TD, Chen D (2019) Mitochondrial Stress\u2010Initiated Aberrant\u00a0Activation of the NLRP3 Inflammasome Regulates the Functional Deterioration of Hematopoietic Stem Cell Aging. Cell Rep 26:945\u2013954","journal-title":"Cell Rep"},{"key":"BFEMBR202154262_CR27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/leu.2009.296","volume":"24","author":"A Matsuoka","year":"2010","unstructured":"Matsuoka A, Tochigi A, Kishimoto M, Nakahara T, Kondo T, Tsujioka T, Tasaka T, Tohyama Y, Tohyama K (2010) Lenalidomide induces cell death in an MDS\u2010derived cell line with deletion of chromosome 5q by inhibition of cytokinesis. Leukemia 24: 748\u2013755","journal-title":"Leukemia"},{"key":"BFEMBR202154262_CR28","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.aaa2361","volume":"347","author":"M Mohrin","year":"2015","unstructured":"Mohrin M, Shin J, Liu Y, Brown K, Luo H, Xi Y, Haynes CM, Chen D (2015) Stem cell aging. A mitochondrial UPR\u2010mediated metabolic checkpoint regulates hematopoietic stem cell aging. Science 347: 1374\u20131377","journal-title":"Science"},{"key":"BFEMBR202154262_CR29","doi-asserted-by":"crossref","unstructured":"Morganti C, Bonora M, Ito K (2019) Improving the accuracy of flow cytometric assessment of mitochondrial membrane potential in hematopoietic stem and progenitor cells through the inhibition of efflux pumps. J Vis Exp 10.3791\/60057","DOI":"10.3791\/60057"},{"key":"BFEMBR202154262_CR30","doi-asserted-by":"crossref","first-page":"11117","DOI":"10.3390\/ijms222011117","volume":"22","author":"C Morganti","year":"2021","unstructured":"Morganti C, Ito K (2021) Mitochondrial contributions to hematopoietic stem cell aging. Int J Mol Sci 22: 11117","journal-title":"Int J Mol Sci"},{"key":"BFEMBR202154262_CR31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nm0996-1011","volume":"2","author":"SJ Morrison","year":"1996","unstructured":"Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL (1996) The aging of hematopoietic stem cells. Nat Med 2: 1011\u20131016","journal-title":"Nat Med"},{"key":"BFEMBR202154262_CR32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/10428199509056846","volume":"17","author":"L Nagarajan","year":"1995","unstructured":"Nagarajan L (1995) Molecular analysis of the 5q\u2010 chromosome. Leuk Lymphoma 17: 361\u2013366","journal-title":"Leuk Lymphoma"},{"key":"BFEMBR202154262_CR33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1349-7006.2006.00270.x","volume":"97","author":"T Naoe","year":"2006","unstructured":"Naoe T, Suzuki T, Kiyoi H, Urano T (2006) Nucleophosmin: a versatile molecule associated with hematological malignancies. Cancer Sci 97: 963\u2013969","journal-title":"Cancer Sci"},{"key":"BFEMBR202154262_CR34","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1073\/pnas.1222861110","volume":"110","author":"WW Pang","year":"2013","unstructured":"Pang WW, Pluvinage JV, Price EA, Sridhar K, Arber DA, Greenberg PL, Schrier SL, Park CY, Weissman IL (2013) Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc Natl Acad Sci USA 110: 3011\u20133016","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR202154262_CR35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20131043","volume":"211","author":"EM Pietras","year":"2014","unstructured":"Pietras EM, Lakshminarasimhan R, Techner JM, Fong S, Flach J, Binnewies M, Passegue E (2014) Re\u2010entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med 211: 245\u2013262","journal-title":"J Exp Med"},{"key":"BFEMBR202154262_CR36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ncb3346","volume":"18","author":"EM Pietras","year":"2016","unstructured":"Pietras EM, Mirantes\u2010Barbeito C, Fong S, Loeffler D, Kovtonyuk LV, Zhang SiYi, Lakshminarasimhan R, Chin CP, Techner J\u2010M, Will B et\u00a0al (2016) Chronic interleukin\u20101 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self\u2010renewal. Nat Cell Biol 18: 607\u2013618","journal-title":"Nat Cell Biol"},{"key":"BFEMBR202154262_CR37","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/leu.2011.270","volume":"26","author":"A Raval","year":"2012","unstructured":"Raval A, Kusler B, Pang WW, Weissman IL, Mitchell BS, Park CY (2012) Effect of nucleophosmin1 haploinsufficiency on hematopoietic stem cells. Leukemia 26: 853\u2013855","journal-title":"Leukemia"},{"key":"BFEMBR202154262_CR38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymeth.2016.12.015","volume":"115","author":"D Sage","year":"2017","unstructured":"Sage D, Donati L, Soulez F, Fortun D, Schmit G, Seitz A, Guiet R, Vonesch C, Unser M (2017) DeconvolutionLab2: An open\u2010source software for deconvolution microscopy. Methods 115: 28\u201341","journal-title":"Methods"},{"key":"BFEMBR202154262_CR39","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2018-10-844654","volume":"133","author":"DA Sallman","year":"2019","unstructured":"Sallman DA, List A (2019) The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. Blood 133: 1039\u20131048","journal-title":"Blood"},{"key":"BFEMBR202154262_CR40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0145-2126(91)90004-D","volume":"15","author":"L Shepherd","year":"1991","unstructured":"Shepherd L, Cameron C, Galbraith P, Windsor S, Lillicrap D (1991) Absence of allelic loss on chromosome 5q by RFLP analysis in preleukemia. Leuk Res 15: 297\u2013303","journal-title":"Leuk Res"},{"key":"BFEMBR202154262_CR41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.V80.2.556.556","volume":"80","author":"PC Shepherd","year":"1992","unstructured":"Shepherd PC, Bond C, Allan NC (1992) Molecular breakpoints and platelet counts in chronic myeloid leukemia. Blood 80: 556\u2013557","journal-title":"Blood"},{"key":"BFEMBR202154262_CR42","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1182\/blood-2007-06-098251","volume":"111","author":"P Sportoletti","year":"2008","unstructured":"Sportoletti P, Grisendi S, Majid SM, Cheng K, Clohessy JG, Viale A, Teruya\u2010Feldstein J, Pandolfi PP (2008) Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse. Blood 111: 3859\u20133862","journal-title":"Blood"},{"key":"BFEMBR202154262_CR43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.hoc.2010.02.008","volume":"24","author":"DT Starczynowski","year":"2010","unstructured":"Starczynowski DT, Karsan A (2010) Innate immune signaling in the myelodysplastic syndromes. Hematol Oncol Clin North Am 24: 343\u2013359","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFEMBR202154262_CR44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19: 477\u2013489","journal-title":"Nat Rev Immunol"},{"key":"BFEMBR202154262_CR45","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","volume":"361","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Vardiman JW (2009) Myelodysplastic syndromes. N Engl J Med 361: 1872\u20131885","journal-title":"N Engl J Med"},{"key":"BFEMBR202154262_CR46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.1994.tb04904.x","volume":"87","author":"K Tohyama","year":"1994","unstructured":"Tohyama K, Tsutani H, Ueda T, Nakamura T, Yoshida Y (1994) Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome. Br J Haematol 87: 235\u2013242","journal-title":"Br J Haematol"},{"key":"BFEMBR202154262_CR47","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201544","volume":"218","author":"JJ Trowbridge","year":"2021","unstructured":"Trowbridge JJ, Starczynowski DT (2021) Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS. J Exp Med 218: e20201544","journal-title":"J Exp Med"},{"key":"BFEMBR202154262_CR48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/leu.2016.276","volume":"31","author":"ME Varney","year":"2017","unstructured":"Varney ME, Choi K, Bolanos L, Christie S, Fang J, Grimes HL, Maciejewski JP, Inoue JI, Starczynowski DT (2017) Epistasis between TIFAB and miR\u2010146a: neighboring genes in del(5q) myelodysplastic syndrome. Leukemia 31: 491\u2013495","journal-title":"Leukemia"},{"key":"BFEMBR202154262_CR49","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.hoc.2011.09.009","volume":"25","author":"SA Wang","year":"2011","unstructured":"Wang SA (2011) Diagnosis of myelodysplastic syndromes in cytopenic patients. Hematol Oncol Clin North Am 25: 1085\u20131110","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFEMBR202154262_CR50","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/2159-8290.CD-21-0177","volume":"11","author":"H\u2010C Wu","year":"2021","unstructured":"Wu H\u2010C, R\u00e9rolle D, Berthier C, Hleihel R, Sakamoto T, Quentin S, Benhenda S, Morganti C, Wu C, Conte L et\u00a0al (2021) Actinomycin D targets NPM1c\u2010primed mitochondria to restore PML\u2010driven senescence in AML therapy. Cancer Discov 11: 3198\u20133213","journal-title":"Cancer Discov"}],"container-title":["The EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.202154262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embr.202154262","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embr.202154262\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embr.202154262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.202154262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:59:53Z","timestamp":1779112793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embr.202154262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,4]]}},"alternative-id":["BFEMBR202154262"],"URL":"https:\/\/doi.org\/10.15252\/embr.202154262","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"EMBR202154262"}}